AN2 Therapeutics, Inc.ANTXNASDAQ
LOADING
|||
Switch Symbol:
ROE: Returns Declining
Trending lower, above historical average, structural decline.
Left:
||||
Return on equity
Latest
-62.70%
↑ 73% above average
Average (5y)
-231.55%
Historical baseline
Range
High:-34.80%
Low:-702.47%
CAGR
-38.3%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | -62.70% | -20.8% |
| 2023 | -51.91% | -20.9% |
| 2022 | -42.94% | -23.4% |
| 2021 | -34.80% | +93.0% |
| 2020 | -494.47% | +29.6% |
| 2019 | -702.47% | - |